Lv3
380 积分 2026-04-03 加入
MON-446 Immunotherapy Induced Thyroiditis Secondary to Nivolumab
19天前
已完结
Immune checkpoint inhibitor-induced thyroiditis and its potential mechanisms
19天前
已完结
Amivantamab plus Lazertinib in Previously Untreated EGFR -Mutated Advanced NSCLC
2个月前
已完结
Amivantamab plus Lazertinib in Previously Untreated EGFR -Mutated Advanced NSCLC
2个月前
已完结
Molecular Profiling across 80,000 Patients with Lung Cancer
2个月前
已完结
Immune checkpoint inhibitors in melanoma
3个月前
已完结
Endocrine toxicities of immune checkpoint inhibitors
3个月前
已完结
The Combined Effect of Immune Checkpoint Inhibitors and Tyrosine Kinase Inhibitors on Thyroid Function
3个月前
已完结
Current evidence on thyroid related adverse events in patients treated with protein tyrosine kinase inhibitors
3个月前
已完结
Role of oxygen sensing and hypoxia-inducible factors in orchestrating innate immune responses
3个月前
已完结
皖公网安备34019202002308
